Target
Plasma kallikrein
Ligand
BDBM50542726
Substrate
n/a
Meas. Tech.
ChEMBL_1987837 (CHEMBL4621384)
IC50
11±n/a nM
Citation
 Lorthiois, ERoache, JBarnes-Seeman, DAltmann, EHassiepen, UTurner, GDuvadie, RHornak, VKarki, RGSchiering, NWeihofen, WAPerruccio, FCalhoun, AFazal, TDedic, DDurand, CDussauge, SFettis, KTritsch, FDentel, CDruet, ALiu, DKirman, LLachal, JNamoto, KBevan, DMo, RMonnet, GMuller, LZessis, RHuang, XLindsley, LCurrie, TChiu, YHFridrich, CDelgado, PWang, SHollis-Symynkywicz, MBerghausen, JWilliams, ELiu, HLiang, GKim, HHoffmann, PHein, ARamage, PD'Arcy, AHarlfinger, SRenatus, MRuedisser, SFeldman, DElliott, JSedrani, RMaibaum, JAdams, CM Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family Approach. J Med Chem 63:8088-8113 (2020) [PubMed]  Article 
Target
Name:
Plasma kallikrein
Synonyms:
Fletcher factor | KLK3 | KLKB1 | KLKB1_HUMAN | Kallikrein | Kininogenin | Plasma kallikrein heavy chain | Plasma kallikrein light chain | Plasma prekallikrein
Type:
Protein
Mol. Mass.:
71391.16
Organism:
Homo sapiens (Human)
Description:
P03952
Residue:
638
Sequence:
MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA
  
Inhibitor
Name:
BDBM50542726
Synonyms:
CHEMBL4642766
Type:
Small organic molecule
Emp. Form.:
C27H28N2O5
Mol. Mass.:
460.5216
SMILES:
CC(C)(C(N)=O)c1cc(COc2ccccc2CC(O)=O)cc(c1)-c1ccc2OC[C@@H](N)c2c1 |r|
Structure:
Search PDB for entries with ligand similarity: